PROSPECTIVE-PRICING STRATEGIES FOR HOSPITAL AND DEPARTMENTAL EFFECTIVENESS - THE PHARMACISTS RESPONSE

[11] McSweeney J M, 1985, Top Health Care Financ, V11, P28

[12] SATHER MR, 1985, AM J HOSP PHARM, V42, P1516

[13] COST-ANALYSIS OF AN AMINOGLYCOSIDE PHARMACOKINETIC DOSING PROGRAM [J]. AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1984, 41 (11): : 2347 - 2351

[14] STEINWACHS DM, 1985, MED CARE, V23, P607, DOI 10.1097/00005650-198505000-00019

[15] REDUCING THE COSTS OF CEPHALOSPORIN THERAPY [J]. AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1985, 42 (07): : 1516 - 1516

[16] 1983, SPSS X

[17] 1983, FED REG, V48, P9774

[18] 1984, FED REG, V49, P4767

[19] 1985, HEALTHCARE FINANC MA, V39, P6

[20] 1983, FED REG, V48, P9751

[11] McSweeney J M, 1985, Top Health Care Financ, V11, P28

[12] SATHER MR, 1985, AM J HOSP PHARM, V42, P1516

[13] COST-ANALYSIS OF AN AMINOGLYCOSIDE PHARMACOKINETIC DOSING PROGRAM [J]. AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1984, 41 (11): : 2347 - 2351

[14] STEINWACHS DM, 1985, MED CARE, V23, P607, DOI 10.1097/00005650-198505000-00019

[15] REDUCING THE COSTS OF CEPHALOSPORIN THERAPY [J]. AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1985, 42 (07): : 1516 - 1516

[16] 1983, SPSS X

[17] 1983, FED REG, V48, P9774

[18] 1984, FED REG, V49, P4767

[19] 1985, HEALTHCARE FINANC MA, V39, P6

[20] 1983, FED REG, V48, P9751